Association of Multiple Gene Polymorphisms Including Homozygous NUDT15 R139C With Thiopurine Intolerance During the Treatment of Acute Lymphoblastic Leukemia
Association of Multiple Gene Polymorphisms Including Homozygous NUDT15 R139C With Thiopurine Intolerance During the Treatment of Acute Lymphoblastic Leukemia
复制标题
包括纯合子 NUDT15 R139C 在内的多基因多态性与急性淋巴细胞白血病治疗期间硫嘌呤不耐受的关联
DOI:
10.1097/mph.0000000000002085
复制
发表时间:
2021
期刊:
影响因子:
--
通讯作者:
Ito E
中科院分区:
文献类型:
--
作者:
Kudo K;Sato T;Takahashi Y;Yuzawa K;Kobayashi A;Kamio T;Sasaki S;Shimada J;Otani K;Tusjimoto S;Kato M;Toki T;Terui K;Ito E
Although thiopurine is a crucial drug for treating acute lymphoblastic leukemia, individual variations in intolerance are observed due to gene polymorphisms. A 3-year-old boy with B-cell precursor acute lymphoblastic leukemia who was administered thiopurine developed mucositis, sepsis, and hemophagocytic lymphohistiocytosis due to prolonged hematologic toxicity, chronic disseminated candidiasis, and infective endocarditis that triggered multiple brain infarctions. The patient was found to harbor 3 gene polymorphisms associated with thiopurine intolerance including homozygous NUDT15 R139C, heterozygous ITPA C94A, and homozygous MTHFR C677T and heterozygous RFC1 G80A. Thus, the combined effect of intolerance via multiple gene polymorphisms should be considered in case of unexpected adverse reactions.